# FDA Inspection 1120887 - CIMBAR PERFORMANCE MINERALS, INC. - January 30, 2020

Source: https://www.keypedia.com/records/fda_inspections/cimbar-performance-minerals-inc/eefce03a-5580-4580-b642-e71df05d12ac
Source feed: FDA_Inspections

> FDA Inspection 1120887 for CIMBAR PERFORMANCE MINERALS, INC. on January 30, 2020. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1120887
- Company Name: CIMBAR PERFORMANCE MINERALS, INC.
- Inspection Date: 2020-01-30
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1275942 - 2025-07-18](https://www.keypedia.com/records/fda_inspections/cimbar-performance-minerals-inc/50586038-4649-43d8-9313-9b860c41325a)
- [FDA Inspection 1275942 - 2025-07-18](https://www.keypedia.com/records/fda_inspections/cimbar-performance-minerals-inc/8ae62435-515b-49da-aad1-5b2b46c0e034)
- [FDA Inspection 1005647 - 2017-02-03](https://www.keypedia.com/records/fda_inspections/cimbar-performance-minerals-inc/b77e5690-fd3f-485b-822a-d341a4f029fa)
- [FDA Inspection 924339 - 2015-04-30](https://www.keypedia.com/records/fda_inspections/cimbar-performance-minerals-inc/f2d0c005-274a-4cef-aabe-80038b16188a)

Company: https://www.keypedia.com/companies/cimbar-performance-minerals-inc/de097cdd-af46-4d14-8566-45a6205d9895

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c